Pierre-Yves Poirier - Profile and Investment Details

Investor Profile

Pierre-Yves Poirier is a Venture Capital, Private Equity Firm, Investor based in Paris, Île-de-France, France with a diverse investment portfolio that includes companies such as Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma, MedDay, HighLife, Groupe ADFGroupe JORYF, Sogetrel, Biogroup-LCD, MMI, Thomson Video Networks, Crescendo Biologics, Netco, Bacacier group, ACE Group, Complexa, walor, Ipside, Genkyotex, Complix, ace credit, SANIFIT, Atlantic Therapeutics, Altavia, Verona Pharma, Chase Pharmaceuticals, Loyalty Company, The Bioclinic Group, Groupe 3S, T-knife, Endosense, Poxel, HR Path, Axonics Modulation Technologies, La Vie Saine, Sfam, Mondial Pet Distribution, Sirsa, ReViral, In'Tech Medical, Inotrem, A2IA, Opportunity, Artios Pharma, GamaMabs Pharma, Corvidia, Mastergrid, Minafin, Maesa Group, Finsecur, orbility, Solware Group, Exciva, Covagen, Avalyn Pharma, LogicBio Therapeutics, erytech, Groupe ERGET, Atland, Medlumics, The Reefer Group, Studia group, Travelsoft, REALEASE Capital, Rougnon, Fortesan, La Toulousaine, Grey Wolf Therapeutics, Globe Groupe, Autonomic Technologies, Tournus Equipement, JenaValve Technology, SPHEREA, Allecra Therapeutics, MS Vacances, Passman, Emeraude International, Dynacure, Tricares, Pennel & Flipo, AgomAb Therapeutics, Arvelle Therapeutics, . Over time, Pierre-Yves Poirier has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Pierre-Yves Poirier is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Hospitals, Wellness, Energy, CRM, Life Science, Robotics, Information Technology (IT), Cloud Computing, Manufacturing, Biotechnology, Electronic Health Records (EHR), Health and Hospital Services, FinTech, Consumer Internet, Consulting, Digital Health, Medical, SaaS, Real Estate, Therapeutics, Media and Entertainment, Material Science, Pharmaceuticals may find it worthwhile to explore potential connections with Pierre-Yves Poirier, as their portfolio suggests a familiarity and interest in this area.

Understanding Pierre-Yves Poirier’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.